Search

You searched for "MET"

632 results found

Is TRUS and biopsy obsolete as a diagnostic test for prostate cancer: refining the perineal biopsy technique?

1 March 2015 | | Urologic Oncology | active surveillance, biopsy, Complications, prostate cancer, staging, transperineal biopsy
Whilst there has been a dramatic shift in how patients are investigated for potential prostate cancer, transrectal ultrasound (TRUS) and biopsy remains the most commonly used technique for tissue sampling. In this single centre, retrospective analysis, 634 men, over a...
The Journal of Urology cover image

Onabotulinum toxin A (BTX) not helpful for chronic scrotal pain

4 September 2020 | | Basic Science Research, Functional Urology | botulinum toxins, nerve block, pelvic pain, scrotum, testis, type A
It is refreshing to read a report on negative outcomes as it reinforces the honesty that is often lacking with the well-known publication bias in medical publications. It is also not common to come across surgical randomised controlled trials (RCTs)...

The PROMIS trial – time for multi-parametric MRI before a first prostate biopsy

1 March 2017 | | Urologic Oncology, Uroradiology
Whilst the relatively random process of 12 core transrectal ultrasound guided (TRUS) prostate biopsy remains by far the most widely employed approach to prostate cancer diagnosis in the UK, its flaws as a standalone diagnostic strategy are increasingly apparent. TRUS-biopsy...

Nurse practitioner TRUS biopsy: training and preparation

1 May 2014 | | Urologic Oncology
As prostate cancer rates increase, many urology departments rely on multi-professional teams to diagnose and manage patients with prostate cancer. The aim of this article is to highlight the skills, training and preparation required for nurse practitioners to undertake trans-rectal...

The Lister Royal College of Surgeons of England / BAUS Accredited Robotic Urological Fellowship Programme

1 September 2015 |
Robotic fellowship training in the UK – overview Robotic surgery has increased in popularity since its introduction in 2003. Its validation in a growing number of operative procedures has increased its acceptance nationwide and its usage is becoming widespread. Initial...

Ejaculatory dysfunction: a review of current practice and guidelines

1 January 2015 | | Andrology
Introduction The ejaculatory process is paramount to procreation in nature. It is a complex orchestration of physiology that results in emission of the ejaculate into the posterior urethra followed by ejection of those fluids from the urethra and orgasm. The...

Read all about it Mar/Apr 2019

1 March 2019 | Functional Urology, Urologic Oncology
Read all about it... It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a ‘cutting-edge’ new treatment / test and you don’t know what they are talking...

The Urology Foundation – 2019 Report

11 December 2019
It has been another busy year for The Urology Foundation in our mission to end the suffering caused by urology disease. We’ve taken big strides in some of the most crucial areas of our work as we work to prevent, treat and cure all urology disease.

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | Functional Urology, Infection, Neurourology, Technological Developments
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...

The role of specialist therapeutic radiographers in the treatment and care of men with prostate cancer

1 March 2016 | | Urologic Oncology
The Statement of Intent: Cancer Strategy for England: 2015-2020 indicates that the number of people diagnosed with cancer each year will continue to grow rapidly due to the ageing population. There is also a requirement to diagnose and offer patients...

Onco-fertility: a review

7 January 2020 | | Andrology, Urologic Oncology
Subfertility or infertility is a major problem affecting men diagnosed with testicular cancer (TC) either due to the disease itself [1], or as a result of management [2]. TC is the most prevalent cancer affecting men of reproductive age [3]....

Demanding cases or nightmares in uro-oncology? May/Jun 2022

3 May 2022 | | Urologic Oncology
Delayed diagnosis of testicular cancer Testicular cancer is considered rare in the general population but is the most common cancer affecting males between 24 and 49 years. The diagnosis of testicular cancer depends on physical examination, ultrasound findings and tumour...